TB-Related Articles
Journal Articles Published by Division of TB Elimination (DTBE) Authors
This is an archived document. The links and content are no longer being updated.
January - December 2006
Andre MD, Ijaz K, Tillinghast JD, Krebs VE, Diem LA, Metchock B, Crisp T, and McElroy PD. Transmission network analysis to complement routine tuberculosis contact investigations. Am J Public Health Nov. 2006; 96(11): 1-8.
Asghar RJ. Promoting regional health cooperation: the South Asian Public Health Forum. PLoS Med 2006; 3(5): e108. Available online May 2006.
Burman W, Benator D, Vernon A, Khan A, Jones B, Silva C, Lahart C, Weis S, King B, Mangura B, Weiner M, El-Sadr W, and Tuberculosis Trials Consortium. Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis. American Journal of Respiratory and Critical Care Med 2006 Feb 1; 173(3): 350-6.
Burman WJ, Goldberg S, Johnson JL, Muzanye G, Engle M, Mosher AW, Choudhri S, Daley CL, Munsiff SS, Zhao Z, Vernon A, Chaisson RE, and the Tuberculosis Trials Consortium. Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. Am J Respir Crit Care Med 2006; 174: 331-338.
Caoili JC, Mayorovo A, Sikes D, Hickman L, Plikaytis BB, Shinnick TM. Evaluation of the TB-Biochip oligonucleotide microarray system for rapid detection of rifampin resistance in Mycobacterium tuberculosis. Journal of Clinical Microbiology 2006 July; 44(7): 2378-2381.
Cattamanchi A, Hopewell P, Gonzalez LC, Osmond DH, Kawamura LM, Daley CL, Jasmer RM. A 13-year molecular epidemiological analysis of tuberculosis in San Francisco. International Journal of Tuberculosis and Lung Disease March 2006; 10(3): 297-304(8).
Clark CM, Driver CR, Munsiff SS, Driscoll JR, Kreiswirth BN, Zhao B, et al. Universal genotyping in tuberculosis control program, New York City, 2001–2003. Emerg Infect Dis 2006 May; 12(5): 719-724. Also available on Internet from http://www.cdc.gov/ncidod/EID/vol12no05/05-0446.htm.
Dewan PK, Grinsdale J, Liska S, Wong E, Fallstad R, Kawamura LM. Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay. BMC Infectious Diseases 2006 Mar 15; 6: 47 [online].
Dewan PK, Lal SS, Lonnroth K, Wares F, Uplekar M, Sahu S, Granich R, and Chauhan LS. Improving tuberculosis control through public-private collaboration in India: literature review. BMJ 2006 Mar 11; 332(7541): 574-8. Also available as e-pub 2006 Feb 8.
Holtz TH, Lancaster J, Laserson KF, Wells CD, Thorpe L, Weyer K. Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999–2001. Int J Tuberc Lung Dis June 2006; 10(6): 649-655.
Holtz TH, Sternberg M, Kammerer S, Laserson K, Riekstina V, Zarovska E, Skripconoka V, Wells C, Leimane V. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome. Annals of Internal Medicine 2006; 144(9): 650-660.
Ijaz K, Jereb J, Lambert L, Bower W, Spradling P, McElroy P, Iademarco M, Navin T, and Castro K. Severe or fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis infection. Clinical Infectious Diseases 2006; 42: 346-355.
Johansen SK, Maus CE, Plikaytis BB, Douthwaite S. Capreomycin binds across the ribosomal subunit interface using tlyA-encoded 2′-O-methylations in 16S and 23S rRNAs. Molecular Cell 2006 July 21; 23: 173-182.
Khan A, Sterling TR, Reves R, Vernon A, Horsburgh CR, and the Tuberculosis Trials Consortium. Lack of weight gain and relapse risk in a large tuberculosis treatment trial. Am J Respir Crit Care Med 2006; 174: 344-348.
Lee LM, Lobato MN, Buskin SE, Morse A, Costa S. Low adherence to guidelines for preventing TB among persons with newly diagnosed HIV infection, United States. International Journal of Tuberculosis and Lung Disease 2006; 10(2): 209-214.
Lobato MN, Wang YC, Becerra JE, Simone PM, and Castro KG. Improved program activities are associated with decreasing tuberculosis incidence in the United States. Public Health Reports 2006 Mar-Apr; 121(2): 108-15.
Lofy KH, McElroy PD, Lake L, Cowan LS, Diem LA, Goldberg SV, Cangelosi GA, Tribble SP, Cave MD, Narita M. Outbreak of tuberculosis in a homeless population involving multiple sites of transmission. Int J Tuberc Lung Dis June 2006; 10(6): 683-689.
Macaraig M, Agerton T, Driver CR, Munsiff SS, Abdelwahab J, Park J, Kreiswirth B, Driscoll J, and Zhao B. Strain-specific differences in two large Mycobacterium tuberculosis genotype clusters in isolates collected from homeless patients in New York City from 2001 to 2004. Journal of Clinical Microbiology 2006 Aug; 44(8): 2890-6.
Maloney SA, Fielding KL, Laserson KF, et al. Assessing the performance of overseas tuberculosis screening programs: a study among US-bound immigrants in Vietnam. Arch Intern Med 2006; (2)166: 234-240.
Manangan LP, Moore M, Macaraig M, MacNeil J, Shevick G, Northrup J, Pratt R, Adams LV, Boutotte J, Sharnprapai S, Qualls N. Health department costs of managing persons with suspected and noncounted tuberculosis in New York City, three Texas counties, and Massachusetts. J Public Health Management and Practice 2006; 12(3): 248-253.
Miller TL, Hilsenrath P, Lykens K, McNabb SJN, Moonan PK, and Weis SE. Using cost and health impacts to prioritize the targeted testing of tuberculosis in the United States. Annals of Epidemiology 2006; 16: 305-312.
Moonan PK, Oppong J, Sahbazian B, Singh KP, Sandhu R, Drewyer G, Lafon T, Marruffo M, Quitugua TN, Wallace C, and Weis SE. What is the outcome of targeted tuberculosis screening based on universal genotyping and location? American Journal of Respiratory and Critical Care Medicine 2006 Sep 1; 174(5): 599-604. Also available as e-pub 2006 May 25.
Mugisha B, Bock N, Mermin J, Odeke RM, Miller B, Adatu-Engwau F, Granich R, Bunnell R. Tuberculosis case finding and preventive therapy in an HIV voluntary counseling and testing center in Uganda. Int J Tuberc Lung Dis July 2006; 10(7): 761-767.
Munsiff SS, Ahuja SD, King L, Udeagu C-C, Dorsinville M, Frieden TR, Fujiwara PI. Ensuring accountability: the contribution of the cohort review method to tuberculosis control in New York City. Int J Tuberc Lung Dis 2006; 10(10): 1133-1139.
Munsiff SS, Ahuja SD, Li J, Driver CR. Public-private collaboration for multidrug-resistant tuberculosis control in New York City. Int J Tuberc Lung Dis June 2006; 10(6): 639-648.
Munsiff SS, Li J, Cook SV, Piatek A, Laraque F, Ebrahimzadeh A, and Fujiwara PI. Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003. Clinical Infectious Diseases 2006 Jun 15; 42(12): 1702-10. Also available as e-pub 2006 May 12.
Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blndal K, et al. Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis 2006 Sept; 12(9): 1389-1397.
Oeltmann JE, Oren E, Haddad MB, Lake LK, Harrington TA, Ijaz K, Narita M. Tuberculosis outbreak in marijuana users—Seattle, Washington, 2004. Emerg Infect Dis 2006 July; 12(7): 1156-1159.
Posey JE, Shinnick TM, and Quinn FD. Characterization of the twin-arginine translocase secretion system of Mycobacterium smegmatis. Journal of Bacteriology 2006 Feb; 188(4): 1332–1340.
Reid A, Scano F, Getahun H, Williams B, Dye C, Nunn P, De Cock KM, Hankins C, Miller B, Castro KG, and Raviglione MC. Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration. The Lancet Infectious Diseases 2006 Aug; 6(8): 483-95.
Roberts C, Lobato M, Bazerman L, Kling R, Reichard A, Hammett T. Tuberculosis prevention and control in large jails: a challenge to tuberculosis education. American Journal of Preventive Medicine 2006: 30(2); 125-130.
Sackoff JE, Pfeiffer MR, Driver CR, Streett LS, Munsiff SS, and DeHovitz JA. Tuberculosis prevention for non-US-born pregnant women. American Journal of Obstetrics and Gynecology 2006 Feb; 194(2): 451-6.
Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB, Bernardo J, Venkataramanan R, and Sterling TR. An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy. American Journal of Respiratory and Critical Care Medicine 2006 Oct 15; 174 (8):935-52.
Shah NS, Harrington T, Huber M, Wellnitz C, Fridrych S, Laserson K, Gonzalez IM, and Ijaz K. Increased reported cases of tuberculosis among children younger than 5 years of age, Maricopa County, Arizona, 2002-2003. The Pediatric Infectious Disease Journal 2006 Feb; 25 (2): 151-5.
Sterling TR, Bethel J, Goldberg S, Weinfurter P, Yun L, Horsburgh CR, and the Tuberculosis Epidemiologic Studies Consortium. The scope and impact of treatment of latent tuberculosis infection in the United States. Am J Respir Crit Care Med 2006; 173:927-931.
Sterling TR, Zhao Z, Khan A, Chaisson RE, Schluger N, Mangura B, Weiner M, Vernon A for the Tuberculosis Trials Consortium. Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis May 2006; 10(5):542-549.
Yagui M, Perales MT, Asencios L, Vergara L, Suarez C, Yale G, Salazar C, Saavedra M, Shin S, Ferrousier O, Cegielski P. Timely diagnosis of MDR-TB under program conditions: is rapid drug susceptibility testing sufficient? Int J Tuberc Lung Dis August 2006; 10(8):838-843.
Contact Us:
- Centers for Disease Control and Prevention
Division of Tuberculosis Elimination (DTBE)
1600 Clifton Rd., NE
MS E10
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - New Hours of Operation
8am-8pm ET/Monday-Friday
Closed Holidays - cdcinfo@cdc.gov
